News & Analysis as of

Intellectual Property law-news Professional Practice

Read Intellectual Property Law updates, alerts, news, and legal analysis from leading lawyers and law firms:
Perkins Coie

How the Trump Administration May Affect AI Policy on Intellectual Property and Deepfakes

Perkins Coie on

As President-elect Donald Trump prepares for his second term, his administration is poised to influence the future of policy surrounding artificial intelligence (AI) and intellectual property (IP), including regulations...more

Weintraub Tobin

(Podcast) The Briefing: A Very Patented Christmas – The Quirkiest Inventions for the Holiday Season

Weintraub Tobin on

Get into the holiday spirit with a look at some of the most unique Christmas patents ever filed. From Santa detectors to upside-down Christmas trees, Scott Hervey and Jamie Lincenberg explore festive inventions that add a...more

Weintraub Tobin

The Briefing: A Very Patented Christmas – The Quirkiest Inventions for the Holiday Season

Weintraub Tobin on

Get into the holiday spirit with a look at some of the most unique Christmas patents ever filed. From Santa detectors to upside-down Christmas trees, Scott Hervey and Jamie Lincenberg explore festive inventions that add a...more

Robinson+Cole Data Privacy + Security Insider

Conclusion of Copyright Office’s Report on Artificial Intelligence Delayed Until 2025

This week, Director Shira Perlmutter indicated that the publication of part two of the U.S. Copyright Office’s three-part report on copyright issues raised by artificial intelligence (AI) would be further delayed. In her...more

McDermott Will & Emery

UPC Issues First FRAND Decision

McDermott Will & Emery on

In a landmark decision, the Unified Patent Court’s (UPC) Local Division Mannheim set standards for enforcing standard essential patents (SEPs) and for negotiating fair, reasonable, and nondiscriminatory (FRAND) licenses under...more

Fish & Richardson

Director Review Spotlight: Applicant Admitted Prior Art

Fish & Richardson on

Over the past two years, Director Vidal has issued two Director Review decisions related to the proper use of Applicant Admitted Prior Art (AAPA) in Patent Trial and Appeal Board (PTAB) proceedings. In both cases, Director...more

Smart & Biggar

A practical guide to Canada’s new Patent Term Adjustment (PTA) system

Smart & Biggar on

On January 1, 2025, Canada will implement a patent term adjustment (PTA) system to account for unreasonable delays by the Canadian Intellectual Property Office (CIPO) in issuing a patent. The final regulations were published...more

Knobbe Martens

Unsupported Expert Testimony Cannot Create a Genuine Issue of Material Fact

Knobbe Martens on

MIRROR WORLDS TECHS., LLC v. META PLATFORMS, INC. - Before Prost, Taranto, and Stark. Appeal from the United States District Court for the Southern District of New York. Summary: Expert testimony that is conclusory,...more

Wolf, Greenfield & Sacks, P.C.

A Conversation with Phil Hamzik

Phil Hamzik is an Associate in Wolf Greenfield’s Pharmaceutical Practice. From protecting key platform technologies to advising on drug product life cycle management, Phil works closely with pharmaceutical and biotechnology...more

Knobbe Martens

Edwards v. Meril at the Supreme Court: Testing the Scope of Hatch-Waxman’s Safe Harbor

Knobbe Martens on

On October 11, 2024, Edwards filed a petition for a writ of certiorari with the U.S. Supreme Court. The question presented, as framed by Edwards, is: “Whether, under Hatch-Waxman’s safe harbor, an infringing act is “solely...more

MoFo Life Sciences

Stop-Gap Spending Bill Provision Takes Aim at Biologics Patent Litigation

MoFo Life Sciences on

UPDATE: The stop-gap spending bill has been revised to remove the provision discussed herein. However, life sciences companies should nonetheless take note of efforts by congress to enact patent-related reforms such as this....more

Goodwin

Bio-Thera Solutions Expands Partnership with SteinCares to Market Two Biosimilars in LATAM

Goodwin on

This Monday, Bio-Thera Solutions announced that it would be expanding its Latin American biosimilar marketing partnership with SteinCares....more

Womble Bond Dickinson

Factors Courts Commonly Consider When Deciding Motions to Transfer in ANDA Litigation

Womble Bond Dickinson on

Where the Operative Facts Occurred - In assessing this primary factor, courts have looked to the location of defendant’s principal place of business, where the ANDA application was prepared, and where the ANDA product was...more

McCarter & English, LLP

Drug Delivery Device Patents Removed from Orange Book

McCarter & English, LLP on

The listing of patents in the Orange Book has an important role in intellectual property protection for pharmaceuticals. Patents listed in the Orange Book can include, without question, patents covering compositions or...more

Rothwell, Figg, Ernst & Manbeck, P.C.

Continued Investment in AI Drug Discovery Points to Potential Future Significance of Inventorship in Biosimilar Litigation

On December 3, 2024, Bristol Myers Squibb announced a collaboration agreement with three-year-old startup AI Proteins. According to its founder, Chris Bahl, PhD, AI Proteins uses “AI, synthetic biology, and laboratory...more

Array

This Week in eDiscovery: Sedona Conference Commentary on Cross-Border Discovery | $845K Spoliation Award

Array on

Every week, the Array team reviews the latest news and analysis about the evolving field of eDiscovery to bring you the topics and trends you need to know. This week’s post covers the period of December 8-14. Here’s what’s...more

Jones Day

French CSPLA Report Highlights AI Regulation: Transparency and Copyright Compliance in Focus

Jones Day on

On December 11, 2024, the French High Council for Literary and Artistic Property ("CSPLA") published a report on the implementation of the European regulation on artificial intelligence ("AI"), focusing on the transparency of...more

Jones Day

Trademark Scams 101: Common Signs of Scams and How to Avoid Them

Jones Day on

Scams related to U.S. trademark filings are becoming more common and sophisticated, making these scams increasingly difficult for trademark owners to identify....more

Jones Day

PTAB Reiterates Strict Evidentiary Standard for Printed Publications

Jones Day on

The PTAB denied institution of inter partes review (IPR) for a patent directed to geothermal technology. Fervo Energy Co. v. Ormat Techs. Inc., IPR2014-00665, Paper 18 (PTAB Sept. 18, 2024). The claimed invention related to...more

Moritt Hock & Hamroff LLP

Rising US Trademark Fees Include Avoidable Surcharges

The United States Patent and Trademark Office (USPTO) has announced changes and increases to certain trademark application filing fees and other charges. The new fees will take effect on January 18, 2025....more

Mintz - Intellectual Property Viewpoints

USPTO Takes a Hint from European Practice in Addressing Late Continuation Concerns

As expected, the United States Patent and Trademark Office (USPTO) is raising its fees this year, effective January 19, 2025. However, the USPTO is doing something a little unusual this time—they’re raising the cost of filing...more

Alston & Bird

Patent Case Summaries | Week Ending December 13, 2024

Alston & Bird on

DDR Holdings, LLC v. Priceline.com LLC, et al., Nos. 2023-1176, -1177 (Fed. Cir. (D. Del.) Dec. 9, 2024). Opinion by Chen, joined by Mayer and Cunningham....more

Vorys, Sater, Seymour and Pease LLP

Putting Whataburger on the Map may Infringe Patents

In Texas, Whataburger is more than a fast food restaurant.  It’s a cultural icon, deeply ingrained in the identity of many Texans.  Founded in Corpus Christi, Texas, Whataburger has been a homegrown favorite for generations...more

WilmerHale

Readily Ascertainable - WilmerHale's Trade Secret Bulletin: October 2024

WilmerHale on

Welcome to WilmerHale’s bulletin on recent trade secret case law and relevant news items. We’ve affectionately nicknamed it “Readily Ascertainable” because, unlike a trade secret, it should be easy to figure out....more

Fenwick & West LLP

What is the IP Risk Profile in AI Drug Discovery?

Fenwick & West LLP on

The scientific benefits and legal risks of AI-driven drug discovery are consequential. But recent IP law decisions allude to a general concept that IP rights will not be awarded if AI completely or significantly replaces...more

39,065 Results
 / 
View per page
Page: of 1,563

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide